HIV Collection
 101-120 of 457 Articles
Original Research |  18 May 2004
Metabolic Effects of Rosiglitazone in HIV Lipodystrophy: A Randomized, Controlled Trial
Colleen Hadigan, MD, MPH; Sigal Yawetz, MD; Abraham Thomas, MD; et al.
Ann Intern Med. 2004;140(10):786-794. doi:10.7326/0003-4819-140-10-200405180-00008
Original Research |  17 February 2004
The Prognostic Importance of Changes in CD4+Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy
Kathryn Anastos, MD; Yolanda Barrón, MS; Mardge H. Cohen, MD; et al.
Ann Intern Med. 2004;140(4):256-264. doi:10.7326/0003-4819-140-4-200402170-00007
Editorials |  17 February 2004
Starting Highly Active Antiretroviral Therapy for HIV Infection: Is It WIHS To Wait?
Robert T. Schooley, MD
Ann Intern Med. 2004;140(4):305-306. doi:10.7326/0003-4819-140-4-200402170-00014
Original Research |  18 November 2003
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L
Evan Wood, PhD; Robert S. Hogg, PhD; Benita Yip, BSc (Pharm); et al.
Ann Intern Med. 2003;139(10):810-816. doi:10.7326/0003-4819-139-10-200311180-00008
Current Clinical Issues |  18 November 2003
The Crucial Link between Literacy and Health
Jennifer Fisher Wilson
Ann Intern Med. 2003;139(10):875-878. doi:10.7326/0003-4819-139-10-200311180-00038
Original Research |  2 September 2003
Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection: A Randomized Trial
Kathleen Squires, MD; Anton L. Pozniak, MD; Gerald Pierone, MD; et al.
Ann Intern Med. 2003;139(5_Part_1):313-320. doi:10.7326/0003-4819-139-5_Part_1-200309020-00006
Original Research |  19 August 2003
Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection: A Randomized, Placebo-Controlled Clinical Trial
Donald I. Abrams, MD; Joan F. Hilton, DSc; Roslyn J. Leiser, RN; et al.
Ann Intern Med. 2003;139(4):258-266. doi:10.7326/0003-4819-139-4-200308190-00008
Original Research |  15 July 2003
Alternation of Antiretroviral Drug Regimens for HIV Infection: A Randomized, Controlled Trial
Javier Martinez-Picado, PhD; Eugènia Negredo, MD, PhD; Lidia Ruiz, PhD; et al.
Ann Intern Med. 2003;139(2):81-89. doi:10.7326/0003-4819-139-2-200307150-00007
Editorials |  15 July 2003
Is It Time To Proactively Switch Successful Antiretroviral Therapy? Carefully Check Your SWATCH
Michael Saag, MD
Ann Intern Med. 2003;139(2):148-149. doi:10.7326/0003-4819-139-2-200307150-00014
Current Clinical Issues |  15 July 2003
Building African AIDS Care from the Ground Up
Jennifer Fisher Wilson
Ann Intern Med. 2003;139(2):157-160. doi:10.7326/0003-4819-139-2-200307150-00028
Original Research |  1 July 2003
Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile
Giuseppe Nunnari, MD; Luciano Nigro, MD; Filippo Palermo, ScD; et al.
Ann Intern Med. 2003;139(1):26-30. doi:10.7326/0003-4819-139-1-200307010-00009
Original Research |  15 April 2003
Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata
Frank J. Palella, MD; Maria Deloria-Knoll, PhD; Joan S. Chmiel, PhD; et al.
Ann Intern Med. 2003;138(8):620-626. doi:10.7326/0003-4819-138-8-200304150-00007
Editorials |  15 April 2003 FREE
When To Start Therapy for HIV Infection: A Swinging Pendulum in Search of Data
H. Clifford Lane, MD; James D. Neaton, PhD
Ann Intern Med. 2003;138(8):680-681. doi:10.7326/0003-4819-138-8-200304150-00018
Original Research |  18 March 2003
High Prevalence of Anal Human Papillomavirus Infection and Anal Cancer Precursors among HIV-Infected Persons in the Absence of Anal Intercourse
Christophe Piketty, MD; Teresa M. Darragh, MD; Maria Da Costa, MSc; et al.
Ann Intern Med. 2003;138(6):453-459. doi:10.7326/0003-4819-138-6-200303180-00008
Reviews |  4 February 2003
Hepatitis C in the HIV-Infected Person
Mark S. Sulkowski, MD; David L. Thomas, MD
Ann Intern Med. 2003;138(3):197-207. doi:10.7326/0003-4819-138-3-200302040-00012
Original Research |  5 November 2002
Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy
Stephen D. Shafran, MD; Laura D. Mashinter, BScN, RN; Peter Phillips, MD; et al.
Ann Intern Med. 2002;137(9):734-737. doi:10.7326/0003-4819-137-9-200211050-00008
Original Research |  15 October 2002
Relationship between Levels of Indinavir in Hair and Virologic Response to Highly Active Antiretroviral Therapy
Louis Bernard, MD; Albert Vuagnat, MD; Gilles Peytavin, MD; et al.
Ann Intern Med. 2002;137(8):656-659. doi:10.7326/0003-4819-137-8-200210150-00009
Editorials |  15 October 2002
Hair It Is: The Long and Short of Monitoring Antiretroviral Treatment
Monica Gandhi, MD, MPH; Ruth M. Greenblatt, MD
Ann Intern Med. 2002;137(8):696-697. doi:10.7326/0003-4819-137-8-200210150-00016
Clinical Guidelines |  3 September 2002 FREE
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
Mark Dybul, MD; Anthony S. Fauci, MD; John G. Bartlett, MD; et al.
Ann Intern Med. 2002;137(5_Part_2):381-433. doi:10.7326/0003-4819-137-5_Part_2-200209031-00001
Clinical Guidelines |  3 September 2002 FREE
Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*
Prepared by Henry Masur, MD; Jonathan E. Kaplan, MD; King K. Holmes, MD, PhD
Ann Intern Med. 2002;137(5_Part_2):435-478. doi:10.7326/0003-4819-137-5_Part_2-200209031-00002
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.